28.10.2011 • News

Majority Stake in CU Chemie Uetikon Sold to Barclays Private Equity

Barclays Private Equity (BPE) has acquired a majority shareholding in CU Chemie Uetikon, a fine chemicals company based in Lahr, Germany.  With a shareholding of 90%, BPE will have a controlling interest in the spin-off from the Swiss group CPH Chemie + Papier Holding AG. Together with management, BPE said it will pursue a consistent growth strategy in pharmaceuticals, cosmetics and nutrition industries. The consideration is undisclosed and completion is subject to regulatory approval.

 

Company

CU Chemie Uetikon

Raiffeisenstr. 4
77933 Lahr
Germany

Company contact







Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.